BO
Boundless Bio, Inc.
BOLD · NASDAQ
$2.60 -2.80% (-$0.07)
1M -10.96%
Market Cap $63.6M
P/E Ratio -
Div. Yield -
ROE 70.89%
Piotroski F-Score Weak
1/9Valuation
100 /100
Cheap P/B 0.96x
EV/FFO N/A
P/E N/A
Growth
-
N/A FCF growth N/A
EPS growth N/A
Book val. growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
0 /100
Poor ROA 86.80%
ROIC 103.08%
Asset turnover 0.00x
Debt
100 /100
Low Current ratio 9.48x
Debt/Equity 0.00x
Debt/Assets N/A
Stability
31 /100
Unstable Profitable years 0
Beta 0.38x
EPS volatility 53.45%
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na BOLD
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Zachary Hornby
Employees
28
Headquarters
San Diego
Nadcházející události
05 LIS
Earnings
Upcoming earnings report